Maravai Lifesciences Holdings (MRVI) Accumulated Depreciation & Amortization (2020 - 2024)
Historic Accumulated Depreciation & Amortization for Maravai Lifesciences Holdings (MRVI) over the last 5 years, with Q4 2024 value amounting to $28.9 million.
- Maravai Lifesciences Holdings' Accumulated Depreciation & Amortization rose 48992.32% to $28.9 million in Q4 2024 from the same period last year, while for Dec 2024 it was $28.9 million, marking a year-over-year increase of 48992.32%. This contributed to the annual value of $28.9 million for FY2024, which is 48992.32% up from last year.
- Per Maravai Lifesciences Holdings' latest filing, its Accumulated Depreciation & Amortization stood at $28.9 million for Q4 2024, which was up 48992.32% from -$7.4 million recorded in Q4 2023.
- In the past 5 years, Maravai Lifesciences Holdings' Accumulated Depreciation & Amortization registered a high of $28.9 million during Q4 2024, and its lowest value of -$9.7 million during Q4 2020.
- Moreover, its 5-year median value for Accumulated Depreciation & Amortization was $5.6 million (2021), whereas its average is $4.7 million.
- Its Accumulated Depreciation & Amortization has fluctuated over the past 5 years, first crashed by 21760.14% in 2023, then surged by 48992.32% in 2024.
- Over the past 5 years, Maravai Lifesciences Holdings' Accumulated Depreciation & Amortization (Quarter) stood at -$9.7 million in 2020, then skyrocketed by 157.64% to $5.6 million in 2021, then increased by 12.55% to $6.3 million in 2022, then tumbled by 217.6% to -$7.4 million in 2023, then surged by 489.92% to $28.9 million in 2024.
- Its Accumulated Depreciation & Amortization stands at $28.9 million for Q4 2024, versus -$7.4 million for Q4 2023 and $6.3 million for Q4 2022.